Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ondra Health vs SexyMD

By GLP-1 ScorecardUpdated

Ondra HealthFactor scores not reassessed.
Site position #5

Higher score

SexyMDFactor scores not reassessed.
Site position #354

Lower score

Score comparison

Ondra Health has the higher recorded score — 86.8/100 to 60.3/100.

Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Ondra publishes monthly and prepaid compounded injection plans with pharmacy choices; compare the upfront bill, eligible pharmacy and early-cancellation repricing before choosing a term.

Before you choose

Before comparing the headline prices, the Ondra Health review and the SexyMD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, Ondra Health vs ShapeIn Rx and Premium Health vs SexyMD compare each of them with another graded program, and the list of alternatives to Ondra Health ranks the programs closest to Ondra Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the GoodLife Health review covers one graded close to these two, at 69.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueOndra Health +53
91
38
Dose & formulationOndra Health +20
84
64
Clinical oversightOndra Health +13
86
73
Labs & monitoringOndra Health +32
84
52
FulfillmentOndra Health +3
88
85
Contract termsOndra Health +19
86
67
Ondra Health · top barSexyMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricOndra HealthSexyMD
WeighScore86.8/10060.3/100
GradeBC
Site position#5#354
Semaglutide$149/mo (compounded; month-to-month)$149/mo (4-week plan; $99/mo on 48-week plan; compounded)
Tirzepatide$219/mo (compounded; month-to-month)$199/mo (4-week plan; $129/mo on 48-week plan; compounded)
CoverageAdvertises 50 states; pharmacy and formulation eligibility varies47 states (all except Arkansas, Mississippi and New Jersey)
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Ondra Health

Site position #5 · B

Factor scores not reassessed.

Strengths

  • Publishes monthly charges and separate upfront totals for longer plans
  • Allows requests for an eligible pharmacy and formulation, subject to prescribing and availability
  • Names independent clinical partners and advertises provider messaging, supplies and shipping

What to consider

  • Six- and twelve-month plans require prepayment and an eligible Hallandale or Vials prescription
  • Early prepaid cancellation reprices each three-month supply already sent at the regular quarterly rate
  • Confirm the selected renewal cutoff and any earned consultation or administrative fees
  • Branded and oral access, included lab testing and independent current certification were not established
SexyMD

Site position #354 · C

Factor scores not reassessed.

Strengths

  • Publishes an exact exclusion list — all states except Arkansas, Mississippi and New Jersey — rather than a nationwide claim
  • States both compounding classes in the Terms, so the class question is answered even though the pharmacy is not named
  • Names the prescribing entity and the professional corporation behind it
  • Sells two microdose products with their own published price tables rather than only as a discount tier

What to consider

  • Every headline price is the 48-week commitment rate: $99 against a four-week figure of $149, and $129 against $199, with an asterisk that resolves to no footnote
  • The same footer, on every page, says both that the service is available in all 50 states and that it is available in all states except three
  • The two microdose products publish identical prices for their 4-, 8- and 12-week plans, in the same table format that carries real tiers elsewhere
  • The microdose page contradicts itself on dosing frequency inside a single page
  • Three unsourced and mutually inconsistent social-proof figures appear across the homepage, the footer and the product pages
  • The checkout claims two patient counts for a single day that together exceed the total the site's own badge claims
  • No pharmacy is named, and what the price includes is never itemized on any product page

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard